Peel Hunt restated their add rating on shares of Udg Healthcare (LON:UDG) in a research report released on Friday. Peel Hunt currently has a GBX 880 ($12.16) price target on the stock.
Other analysts have also recently issued research reports about the stock. Stifel Nicolaus reissued a hold rating and set a GBX 815 ($11.26) price objective on shares of Udg Healthcare in a report on Thursday, November 30th. Jefferies Group reissued a hold rating and set a GBX 820 ($11.33) price objective on shares of Udg Healthcare in a report on Wednesday, January 17th. Liberum Capital reissued a hold rating and set a GBX 884 ($12.21) price objective on shares of Udg Healthcare in a report on Tuesday, November 28th. N+1 Singer reissued a hold rating and set a GBX 813 ($11.23) price objective on shares of Udg Healthcare in a report on Wednesday, February 7th. Finally, Libertas Partners raised shares of Udg Healthcare to a buy rating and set a GBX 884 ($12.21) target price on the stock in a report on Wednesday, February 7th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the stock. Udg Healthcare has an average rating of Hold and a consensus price target of GBX 832.63 ($11.50).
Udg Healthcare (LON:UDG) traded up GBX 6.50 ($0.09) during mid-day trading on Friday, reaching GBX 839.50 ($11.60). 907,336 shares of the company’s stock were exchanged, compared to its average volume of 873,597. Udg Healthcare has a 12 month low of GBX 663 ($9.16) and a 12 month high of GBX 963 ($13.30). The firm has a market capitalization of $2,080.00 and a PE ratio of 3,997.62.
The firm also recently announced a dividend, which was paid on Monday, February 5th. Stockholders of record on Thursday, January 11th were issued a $0.10 dividend. This represents a dividend yield of 0.84%. This is a boost from Udg Healthcare’s previous dividend of $0.04. The ex-dividend date was Thursday, January 11th.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/02/24/udg-healthcares-udg-add-rating-reaffirmed-at-peel-hunt-2.html.
About Udg Healthcare
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.